Pulse Biosciences

Pulse Biosciences is a company listed under the stock ticker PLSE (US).

View the org chart displaying its 17 main executives

Most searched biographies at Pulse Biosciences

• Kevin Danahy, Chief Executive Officer
• Mahkam Zanganeh, Director
• Manmeet Soni, Director

Popular executive movements at Pulse Biosciences

• Niv Ad has joined the company as Chief Science Officer, Cardiac Surgery  (posted on October 25 2023).

Create your alert
to follow the executive moves at Pulse Biosciences.

Pulse Biosciences has 2,284 competitors including Lonza (Switzerland), Eurofins (Luxembourg) and Adaptive Phage Therapeutics (United States (USA)).

Popular M&A news in Biotechnology

• Transcarent has just announced a $126 Million fundraising (posted on May 2 2024).
• WindRose Health Investors has announced the acquisition of SubjectWell  (posted on May 2 2024).
• Enlaza Therapeutics has just announced a $100 Million fundraising (posted on May 2 2024).

Popular contacts in Biotechnology

• Ali Behbahani - Non-Executive Director at Adaptimmune Therapeutics
• Vik Bajaj - Director at Interline Therapeutics
• Khalil Barrage - Interim Chairman of the Board at Sensorion

Learn more about the Biotechnology industry >

Press releases by Pulse Biosciences

• Pulse Biosciences Receives FDA 510(k) Clearance of Expanded Energy Settings for use with the CellFX® System | Pulse Biosciences Inc.
• Pulse Biosciences Schedules Second Quarter 2022 Financial Results Conference Call for August 10, 2022 | Pulse Biosciences Inc.
• Pulse Biosciences Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | Pulse Biosciences Inc.
• Pulse Biosciences, Inc. Announces the Closing of Its Rights Offering | Pulse Biosciences Inc.
• Pulse Biosciences, Inc. Announces Preliminary Results for its Rights Offering | Pulse Biosciences Inc.
• Pulse Biosciences, Inc. Announces Changes to its Rights Offering | Pulse Biosciences Inc.
• Pulse Biosciences, Inc. Announces Commencement of Rights Offering | Pulse Biosciences Inc.
• Pulse Biosciences Schedules First Quarter 2022 Financial Results Conference Call for May 11, 2022 | Pulse Biosciences Inc.
• Pulse Biosciences to Present New Data on Nano-Pulse Stimulation Procedure for Sebaceous Hyperplasia and for Focal Epithelial Hyperplasia at 2022 American Society of Laser Medicine and Surgery Annual Conference | Pulse Biosciences Inc.
• Pulse Biosciences, Inc. Announces Rights Offering | Pulse Biosciences Inc.
• View more press releases Close

Social media about Pulse Biosciences

• Pulse Biosciences on Wikipedia, Google News & Yahoo Finance
• Pulse Biosciences on LinkedIn, Twitter & YouTube

Contact by email its executives including Manmeet Soni

Call Pulse Biosciences at +1 650...

View the org chart

Register to receive your alert

Report an error